The DOI matches its Crossref record; 391 of the 391 references it cites were found in a registry or an index.
Approved Antiviral Drugs over the Past 50 Years
Open accessAbstract
SUMMARY: Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs categorized into 13 functional groups have been formally approved for the treatment of the following 9 human infectious diseases: (i) HIV infections (protease inhibitors, integrase inhibitors, entry inhibitors, nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and acyclic nucleoside phosphonate analogues), (ii) hepatitis B virus (HBV) infections (lamivudine, interferons, nucleoside analogues, and acyclic nucleoside phosphonate analogues), (iii) hepatitis C virus (HCV) infections (ribavirin, interferons, NS3/4A protease inhibitors, NS5A inhibitors, and NS5B polymerase inhibitors), (iv) herpesvirus infections (5-substituted 2′-deoxyuridine analogues, entry inhibitors, nucleoside analogues, pyrophosphate analogues, and acyclic guanosine analogues), (v) influenza virus infections (ribavirin, matrix 2 protein inhibitors, RNA polymerase inhibitors, and neuraminidase inhibitors), (vi) human cytomegalovirus infections (acyclic guanosine analogues, acyclic nucleoside phosphonate analogues, pyrophosphate analogues, and oligonucleotides), (vii) varicella-zoster virus infections (acyclic guanosine analogues, nucleoside analogues, 5-substituted 2′-deoxyuridine analogues, and antibodies), (viii) respiratory syncytial virus infections (ribavirin and antibodies), and (ix) external anogenital warts caused by human papillomavirus infections (imiquimod, sinecatechins, and podofilox). Here, we present for the first time a comprehensive overview of antiviral drugs approved over the past 50 years, shedding light on the development of effective antiviral treatments against current and emerging infectious diseases worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–391 of 391
The dengue virus NS5 protein as a target for drug discovery
Lim, S. P., Noble, C. G., & Shi, P.-Y. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.04.010 · Cited by 239
Soudeyns, H., Yao, X. I., Gao, Q., Belleau, B., Kraus, J. L., Nguyen-Ba, N., Spira, B., & Wainberg, M. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1386 · Cited by 237
Benefits and risks of interferon therapy for hepatitis B #
Perrillo, R. (2009) · Hepatology · doi:10.1002/hep.22956 · Cited by 236
Substandard/Counterfeit Antimicrobial Drugs
Kelesidis, T., & Falagas, M. E. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-14 · Cited by 236
Treatment of herpes simplex virus infections
Brady, R. C., & Bernstein, D. I. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2003.09.006 · Cited by 233
Pathogenesis and Current Approaches to Control of Varicella-Zoster Virus Infections
Gershon, A. A., & Gershon, M. D. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00052-13 · Cited by 233
Smither, S. J., Eastaugh, L. S., Steward, J. A., Nelson, M., Lenk, R. P., & Lever, M. S. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.01.012 · Cited by 228
Viruses and Human Cancers: a Long Road of Discovery of Molecular Paradigms
White, M. K., Pagano, J. S., & Khalili, K. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00124-13 · Cited by 228
Amantadine: The journey from fighting flu to treating Parkinson disease
Hubsher, G., Haider, M., & Okun, M. S. (2012) · Neurology · doi:10.1212/wnl.0b013e31824e8f0d · Cited by 227
Kitrinos, K. M., Corsa, A., Liu, Y., Flaherty, J., Snow-Lampart, A., Marcellin, P., Borroto-Esoda, K., & Miller, M. D. (2014) · Hepatology · doi:10.1002/hep.26686 · Cited by 226
Jiang, P., Liu, Y., Ma, H.-C., Paul, A. V., & Wimmer, E. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-14 · Cited by 226
Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts
Beutner, K. R., Tyring, S. K., Trofatter, K. F., Douglas, J. M., Spruance, S., Owens, M. L., Fox, T. L., Hougham, A. J., & Schmitt, K. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.789 · Cited by 225
Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health
Middleton, D., Pallister, J., Klein, R., Feng, Y.-R., Haining, J., Arkinstall, R., Frazer, L., Huang, J.-A., Edwards, N., Wareing, M., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2003.131159 · Cited by 223
Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?
Cheng, V. C. C., To, K. K. W., Tse, H., Hung, I. F. N., & Yuen, K.-Y. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05012-11 · Cited by 223
(2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01327-2 · Cited by 222
The history of cytomegalovirus and its diseases
Ho, M. (2008) · Medical Microbiology and Immunology · doi:10.1007/s00430-007-0066-x · Cited by 218
Origin of the HIV-1 group O epidemic in western lowland gorillas
D’arc, M., Ayouba, A., Esteban, A., Learn, G. H., Boué, V., Liegeois, F., Etienne, L., Tagg, N., Leendertz, F. H., Boesch, C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502022112 · Cited by 215
Architecture of respiratory syncytial virus revealed by electron cryotomography
Liljeroos, L., Krzyzaniak, M. A., Helenius, A., & Butcher, S. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309070110 · Cited by 215
Zaia, J. A., Levin, M. J., Preblud, S. R., Leszczynski, J., Wright, G. G., Ellis, R. J., Curtis, A. C., Valerio, M. A., & LeGore, J. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.4.737 · Cited by 211
TAUBENBERGER, J. K., & MORENS, D. M. (2009) · Revue Scientifique et Technique de l'OIE · doi:10.20506/rst.28.1.1879 · Cited by 208
T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
Kiso, M., Takahashi, K., Sakai-Tagawa, Y., Shinya, K., Sakabe, S., Le, Q. M., Ozawa, M., Furuta, Y., & Kawaoka, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909603107 · Cited by 207
Margolis, D. A., Brinson, C. C., Smith, G. H. R., de Vente, J., Hagins, D. P., Eron, J. J., Griffith, S. K., Clair, M. H. S., Stevens, M. C., Williams, P. E., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00152-8 · Cited by 204
The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A)
Schabel Jr., F. M. (1968) · Chemotherapy · doi:10.1159/000220567 · Cited by 204
Introduction to the Biochemistry of D-Arabinosyl Nucleosides
Cohen, S. S. (1966) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60231-7 · Cited by 202
Ren, J., Bird, L. E., Chamberlain, P. P., Stewart-Jones, G. B., Stuart, D. I., & Stammers, D. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222366699 · Cited by 201
de Vries, J. J. C., van Zwet, E. W., Dekker, F. W., Kroes, A. C. M., Verkerk, P. H., & Vossen, A. C. T. M. (2013) · Reviews in Medical Virology · doi:10.1002/rmv.1744 · Cited by 195
Das, K., Ding, J., Hsiou, Y., Clark, A. D., Moereels, H., Koymans, L., Andries, K., Pauwels, R., Janssen, P. A. J., Boyer, P. L., et al. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0698 · Cited by 188
Fomivirsen – a phosphorothioate oligonucleotide for the treatment of CMV retinitis
de Smet, M. D., Meenken, C., & van den Horn, G. J. (1999) · Ocular Immunology and Inflammation · doi:10.1076/ocii.7.3.189.4007 · Cited by 187
The history of antiretrovirals: key discoveries over the past 25 years
De Clercq, E. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.624 · Cited by 184
Self-citationDrexler, J. F., Geipel, A., König, A., Corman, V. M., van Riel, D., Leijten, L. M., Bremer, C. M., Rasche, A., Cottontail, V. M., Maganga, G. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308049110 · Cited by 184
The Origin of Hepatitis C Virus
Simmonds, P. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-27340-7_1 · Cited by 183
Systematic Review of the Biology and Medical Management of Respiratory Syncytial Virus Infection
Black, C. (2003) · Respiratory Care · doi:10.4187/respcare.03480209 · Cited by 178
Wilhelmus, K. R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002898.pub5 · Cited by 178
Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
McCauley, J. A., McIntyre, C. J., Rudd, M. T., Nguyen, K. T., Romano, J. J., Butcher, J. W., Gilbert, K. F., Bush, K. J., Holloway, M. K., Swestock, J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9015526 · Cited by 178
25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end
Heim, M. H. (2013) · Nature reviews. Immunology · doi:10.1038/nri3463 · Cited by 178
Johnston, C., & Corey, L. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-15 · Cited by 177
Baba, M., De Clercq, E., Tanaka, H., Ubasawa, M., Takashima, H., Sekiya, K., Nitta, I., Umezu, K., Nakashima, H., & Mori, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2356 · Cited by 176
Self-citationHuman Papillomavirus Laboratory Testing: the Changing Paradigm
Burd, E. M. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-15 · Cited by 176
Reichert, J. M. (2016) · mAbs · doi:10.1080/19420862.2015.1125583 · Cited by 175
Clinical Implications of Antiviral Resistance in Influenza
Li, T., Chan, M., & Lee, N. (2015) · Viruses · doi:10.3390/v7092850 · Cited by 175
Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis
Ganguly, N., & Parihar, S. P. (2009) · Journal of Biosciences · doi:10.1007/s12038-009-0013-7 · Cited by 174
Varicella in Americans from NHANES III: Implications for control through routine immunization
Kilgore, P. E., Kruszon-Moran, D., Seward, J. F., Jumaan, A., Van Loon, F. P. L., Forghani, B., McQuillan, G. M., Wharton, M., Fehrs, L. J., Cossen, C. K., et al. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10364 · Cited by 172
Molina, J.-M., LaMarca, A., Andrade-Villanueva, J., Clotet, B., Clumeck, N., Liu, Y.-P., Zhong, L., Margot, N., Cheng, A. K., & Chuck, S. L. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70249-3 · Cited by 171
Varicella–Zoster Vaccine for the Prevention of Herpes Zoster
Kimberlin, D. W., & Whitley, R. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmct066061 · Cited by 169
(2013) · The Lancet · doi:10.1016/s0140-6736(13)61164-2 · Cited by 169
Kimberlin, D. W., & Rouse, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp023065 · Cited by 168
Debyser, Z., Pauwels, R., Andries, K., Desmyter, J., Kukla, M., Janssen, P. A., & De Clercq, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1451 · Cited by 168
Self-citationGreenup, A.-J., Tan, P. K., Nguyen, V., Glass, A., Davison, S., Chatterjee, U., Holdaway, S., Samarasinghe, D., Jackson, K., Locarnini, S. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.038 · Cited by 167
Pinto, M., & Dobson, S. (2014) · Journal of Infection · doi:10.1016/j.jinf.2013.09.009 · Cited by 167
Clinical Aspects of Marburg Hemorrhagic Fever
Mehedi, M., Groseth, A., Feldmann, H., & Ebihara, H. (2011) · Future Virology · doi:10.2217/fvl.11.79 · Cited by 167
Brouwer, W. P., Xie, Q., Sonneveld, M. J., Zhang, N., Zhang, Q., Tabak, F., Streinu‐Cercel, A., Wang, J., Idilman, R., Reesink, H. W., et al. (2015) · Hepatology · doi:10.1002/hep.27586 · Cited by 166
Vaccines for preventing herpes zoster in older adults
Gagliardi, A. M., Andriolo, B. N., Torloni, M. R., & Soares, B. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008858.pub3 · Cited by 166
Host Immune Status and Response to Hepatitis E Virus Infection
Krain, L. J., Nelson, K. E., & Labrique, A. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00062-13 · Cited by 166
Ku, C.-C., Besser, J., Abendroth, A., Grose, C., & Arvin, A. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2651-2658.2005 · Cited by 166
Andrews, C. D., Spreen, W. R., Mohri, H., Moss, L., Ford, S., Gettie, A., Russell-Lodrigue, K., Bohm, R. P., Cheng-Mayer, C., Hong, Z., et al. (2014) · Science · doi:10.1126/science.1248707 · Cited by 164
Reservoir Host Immune Responses to Emerging Zoonotic Viruses
Mandl, J. N., Ahmed, R., Barreiro, L. B., Daszak, P., Epstein, J. H., Virgin, H. W., & Feinberg, M. B. (2014) · Cell · doi:10.1016/j.cell.2014.12.003 · Cited by 164
Antiviral Therapies and Prospects for a Cure of Chronic Hepatitis B
Zoulim, F., & Durantel, D. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021501 · Cited by 163
Hou, J., Yin, Y.-K., Xu, D., Tan, D., Niu, J., Zhou, X., Wang, Y., Zhu, L., He, Y., Ren, H., et al. (2008) · Hepatology · doi:10.1002/hep.22075 · Cited by 160
Respiratory syncytial virus prevention and therapy: Past, present, and future
Wright, M. L., & Piedimonte, G. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21377 · Cited by 160
An integrated map of HIV genome-wide variation from a population perspective
Li, G., Piampongsant, S., Faria, N. R., Voet, A. R. D., Pineda-Peña, A.-C., Khouri, R., Lemey, P., Vandamme, A., & Theys, K. (2015) · Retrovirology · doi:10.1186/s12977-015-0148-6 · Cited by 159
Self-citationBonagura, V. R., Hatam, L., Rosenthal, D. W., VOTI, J. A. D., Lam, F., Steinberg, B. M., & Abramson, A. L. (2010) · Apmis · doi:10.1111/j.1600-0463.2010.02617.x · Cited by 158
Berger, C., Romero‐Brey, I., Radujković, D., Terreux, R., Zayas, M., Paul, D., Harak, C., Hoppe, S., Gao, M., Pénin, F., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.019 · Cited by 158
HIV-1 entry inhibitors: an overview
Kuritzkes, D. R. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328322402e · Cited by 156
Effectiveness of Hepatitis B Treatment in Clinical Practice
Scaglione, S., & Lok, A. S.-F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.044 · Cited by 155
Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus
Empey, K. M., Peebles, R. S., & Kolls, J. K. (2010) · Clinical Infectious Diseases · doi:10.1086/651603 · Cited by 155
Novel antigens for RSV vaccines
Graham, B. S., Modjarrad, K., & McLellan, J. S. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.04.005 · Cited by 154
Antivirals: Past, present and future
Clercq, E. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.011 · Cited by 152
Sinecatechins, a Defined Green Tea Extract, in the Treatment of External Anogenital Warts
Tatti, S., Swinehart, J. M., Thielert, C., Tawfik, H., Mescheder, A., & Beutner, K. R. (2008) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181719b60 · Cited by 152
Acyclic nucleoside phosphonates: Past, present and future
Clercq, E. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.014 · Cited by 149
Fung, S., Kwan, P., Fabri, M., Horban, A., Pelemis, M., Hann, H.-W., Gurel, S., Caruntu, F. A., Flaherty, J. F., Massetto, B., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.028 · Cited by 147
(2006) · PEDIATRICS · doi:10.1542/peds.2006-1181 · Cited by 147
Recent highlights in the development of new antiviral drugs
Clercq, E. D. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.010 · Cited by 145
Update on Influenza Diagnostics: Lessons from the Novel H1N1 Influenza A Pandemic
Kumar, S., & Henrickson, K. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05016-11 · Cited by 145
Cady, S. D., Mishanina, T. V., & Hong, M. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.11.022 · Cited by 144
In Vitro Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor
Lai, M., Feng, M., Falgueyret, J., Tawa, P., Witmer, M. V., DiStefano, D. J., Li, Y., Burch, J. D., Sachs, N. A., Lu, M., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02403-13 · Cited by 143
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver
Blumberg, B. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7121 · Cited by 140
HIV-1 entry inhibitors: recent development and clinical use
Henrich, T. J., & Kuritzkes, D. R. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.12.002 · Cited by 140
Lepist, E., Phan, T. K., Roy, A., Tong, L., Staiger, K. M., Murray, B. P., & Ray, A. S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01089-12 · Cited by 138
Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster
Clercq, E. D. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.039 · Cited by 137
Structural basis of HIV-1 resistance to AZT by excision
Tu, X., Das, K., Han, Q., Bauman, J. D., Clark, A. D., Hou, X., Frenkel, Y. V., Gaffney, B. L., Jones, R. A., Boyer, P. L., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1908 · Cited by 136
Muir, A. J., Poordad, F. F., Lalezari, J. P., Everson, G. T., Dore, G. J., Herring, R., Sheikh, A. M., Kwo, P. Y., Hézode, C., Pockros, P. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.3868 · Cited by 134
Drug–drug interactions during antiviral therapy for chronic hepatitis C
Kiser, J. J., Burton, J. R., & Everson, G. T. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.106 · Cited by 134
Clercq, E. D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.027 · Cited by 132
Clinical Use of HIV Integrase Inhibitors: A Systematic Review and Meta-Analysis
Messiaen, P., Wensing, A. M. J., Fun, A., Nijhuis, M., Brusselaers, N., & Vandekerckhove, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052562 · Cited by 131
Roquebert, B., Damond, F., Collin, G., Matheron, S., Peytavin, G., Bénard, A., Campa, P., Chêne, G., Brun‐Vézinet, F., Descamps, D., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn335 · Cited by 131
Role of Marine Natural Products in the Genesis of Antiviral Agents
Gogineni, V., Schinazi, R. F., & Hamann, M. T. (2015) · Chemical Reviews · doi:10.1021/cr4006318 · Cited by 127
Baba, M., Shigeta, S., Yuasa, S., Takashima, H., Sekiya, K., Ubasawa, M., TANAKA, H., MIYASAKA, T., Walker, R. T., & Clercq, E. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.688 · Cited by 123
Human parvovirus B19: A review
Rogo, L. D., Mokhtari‐Azad, T., Hamid, K. M., & REZAEI, F. (2014) · Acta Virologica · doi:10.4149/av_2014_03_199 · Cited by 123
Hepatitis C: diagnosis and treatment.
Wilkins, T., Malcolm, J. K., Raina, D., & Schade, R. R. (2010) · PubMed · Cited by 121
Respiratory Infections in the U.S. Military: Recent Experience and Control
Sánchez, J. L., Cooper, M. J., Myers, C. A., Cummings, J. F., Vest, K. G., Russell, K. L., Sanchez, J. L., Hiser, M. J., & Gaydos, C. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00039-14 · Cited by 121
Chikungunya virus: an update on antiviral development and challenges
Kaur, P., & Chu, J. J. H. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.002 · Cited by 120
Status of vaccine research and development of vaccines for Nipah virus
Satterfield, B. A., Dawes, B. E., & Milligan, G. N. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.12.075 · Cited by 120
A new ensemble coevolution system for detecting HIV-1 protein coevolution
Li, G., Theys, K., Verheyen, J., Pineda-Peña, A.-C., Khouri, R., Piampongsant, S., Eusébio, M., Ramon, J., & Vandamme, A. (2015) · Biology Direct · doi:10.1186/s13062-014-0031-8 · Cited by 114
Self-citationChang, C., Lo, S.-C., Wang, Y., & Hou, M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.015 · Cited by 113
HSV trafficking and development of gene therapy vectors with applications in the nervous system
Frampton, A. R., Goins, W. F., Nakano, K., Burton, E. A., & Glorioso, J. C. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302545 · Cited by 112
Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy
Gnann, J. W., Sköldenberg, B., Hart, J., Aurelius, E., Schliamser, S. E., Studahl, M., Eriksson, B.-M., Hanley, D. F., Aoki, F. Y., Jackson, A. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ369 · Cited by 111
Everson, G. T., Towner, W. J., Davis, M. N., Wyles, D. L., Nahass, R., Thuluvath, P. J., Etzkorn, K., Hinestrosa, F., Tong, M. J., Rabinovitz, M., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-1000 · Cited by 111
Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex.
Katz, D. H., Marcelletti, J. F., Khalil, M., Pope, L. E., & Katz, L. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10825 · Cited by 109
Inhibition of HIV‐2 Protease by HIV‐1 Protease Inhibitors in Clinical Use
Brower, E. T., Bacha, U., Kawasaki, Y., & Freire, E. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00647.x · Cited by 109
Status of vaccine research and development of vaccines for dengue
Vannice, K., Durbin, A. P., & Hombach, J. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.12.073 · Cited by 107
Surveying the global virome: Identification and characterization of HCV-related animal hepaciviruses
Scheel, T. K. H., Peter Simmonds, K., & Kapoor, A. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.014 · Cited by 104
Lucey, D. R., & Gostin, L. O. (2016) · JAMA · doi:10.1001/jama.2016.0904 · Cited by 104
Cryo-EM Structure of Influenza Virus RNA Polymerase Complex at 4.3 Å Resolution
Chang, S., Sun, D., Liang, H., Wang, J., Li, J., Guo, L., Wang, X., Guan, C., Boruah, B. M., Yuan, L., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.031 · Cited by 103
Poordad, F. F., Sievert, W., Mollison, L. C., Bennett, M., Tse, E., Bräu, N., Levin, J. M., Sepe, T. E., Lee, S. S., Angus, P., et al. (2015) · JAMA · doi:10.1001/jama.2015.3860 · Cited by 102
Andrews, C. D., Yueh, Y. L., Spreen, W. R., Bernard, L. S., Boente-Carrera, M., Rodriguez, K., Gettie, A., Russell‐Lodrigue, K., Blanchard, J., Ford, S. L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010298 · Cited by 102
New therapies from old medicines
Chen, S. T., Dou, J., Temple, R., Agarwal, R., Wu, K.-M., & Walker, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1008-1077 · Cited by 101
Gross, G., Meyer, K., Pres, H., Thielert, C., Tawfik, H., & Mescheder, A. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02441.x · Cited by 101
Safety and Efficacy of 0.5% Podofilox Gel in the Treatment of Anogenital Warts
Tyring, S. K., Edwards, L., Cherry, L. K., Ramsdell, W. M., Kotner, S., Greenberg, M., Vance, J. C., Barnum, G., Dromgoole, S. H., Killey, F. P., et al. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.1.33 · Cited by 98
Non-M Variants of Human Immunodeficiency Virus Type 1
Mourez, T., Simon, F., & Plantier, J. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00012-13 · Cited by 96
Amantadine and rimantadine for influenza A in children and the elderly
Galvão, M. G. A., Santos, M. A. R. C., & da Cunha, A. J. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002745.pub2 · Cited by 95
Lim, Y., Yoo, B. C., Byun, K. S., Kwon, S. Y., Kim, Y. J., An, J., Lee, H. C., & Lee, Y. S. (2015) · Gut · doi:10.1136/gutjnl-2014-308435 · Cited by 94
Human papillomavirus: clinical manifestations and prevention.
Juckett, G., & Hartman-Adams, H. (2010) · PubMed · Cited by 94
Dawn of non-nucleoside inhibitor-based anti-HIV microbicides
D’Cruz, O. J., & Uckun, F. M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki464 · Cited by 93
Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections
Dropulic, L. K., & Cohen, J. I. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.178 · Cited by 92
Natural reservoirs for homologs of hepatitis C virus
Pfaender, S., Brown, R. J. P., Pietschmann, T., & Steinmann, E. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.19 · Cited by 90
Targeting dengue virus NS4B protein for drug discovery
Xie, X., Zou, J., Wang, Q.-Y., & Shi, P. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.03.007 · Cited by 90
Dengue Hemorrhagic Fever at 60 Years: Early Evolution of Concepts of Causation and Treatment
Halstead, S. B., & Cohen, S. N. (2015) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00009-15 · Cited by 89
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
Orr, R. M. (2001) · PubMed · Cited by 88
Green tea: potential health benefits.
Schneider, C., & Segre, T. (2009) · PubMed · Cited by 87
Ebola virus (EBOV) infection: Therapeutic strategies
Clercq, E. D. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.11.008 · Cited by 87
Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs
Ward, J. W., & Mermin, J. (2015) · New England Journal of Medicine · doi:10.1056/nejme1513245 · Cited by 87
Baba, M., Miyake, H., Wang, X., Okamoto, M., & Takashima, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01079-06 · Cited by 86
Novel therapeutic strategies targeting HIV integrase
Quashie, P. K., Sloan, R. D., & Wainberg, M. A. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-34 · Cited by 85
Is there a future for antiviral fusion inhibitors?
Berkhout, B., Eggink, D., & Sanders, R. W. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.01.002 · Cited by 83
Management of direct-acting antiviral agent failures
Buti, M., Riveiro‐Barciela, M., & Esteban, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.010 · Cited by 82
The discovery of antiviral agents: Ten different compounds, ten different stories
Clercq, E. D. (2008) · Medicinal Research Reviews · doi:10.1002/med.20128 · Cited by 82
Vaccines and Immunotherapeutics for the Prevention and Treatment of Infections with West Nile Virus
Beasley, D. W. C. (2011) · Immunotherapy · doi:10.2217/imt.10.93 · Cited by 82
Peramivir: an intravenous neuraminidase inhibitor
McLaughlin, M. M., Skoglund, E. W., & Ison, M. G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1066336 · Cited by 81
Current status and prospects for development of an HSV vaccine
Johnston, C., Koelle, D. M., & Wald, A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.066 · Cited by 81
Prevention of Hepatitis BPreprint
Chang, M., & Chen, D. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021493 · Cited by 81
Radzio, J., Spreen, W. R., Yueh, Y. L., Mitchell, J. M., Jenkins, L. T., Garcia-Lerma, J. G., & Heneine, W. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010297 · Cited by 80
Lai, C., Ahn, S. H., Lee, K. S., Um, S. H., Cho, M., Yoon, S. K., Lee, J., Park, N. H., Kweon, Y.-O., Sohn, J. H., et al. (2013) · Gut · doi:10.1136/gutjnl-2013-305138 · Cited by 79
Shuaib, W., Stanazai, H., Abazid, A. G., & Mattar, A. A. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.02.027 · Cited by 79
Clercq, E. D. (2009) · Medicinal Research Reviews · doi:10.1002/med.20153 · Cited by 77
Zell, R., Taudien, S., Pfaff, F., Wutzler, P., Platzer, M., & Sauerbrei, A. (2011) · Journal of Virology · doi:10.1128/jvi.06233-11 · Cited by 76
Slavuljica, I., Kveštak, D., Huszthy, P. C., Kosmac, K., Britt, W. J., & Jonjić, S. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.51 · Cited by 75
Small molecule inhibitors of ebola virus infection
Picazo, E., & Giordanetto, F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.010 · Cited by 73
Human cytomegalovirus virion proteins
Britt, W. J., & Boppana, S. B. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.02.008 · Cited by 71
Genital and perianal warts: new treatment opportunities for human papillomavirus infection
Gunter, J. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00789-0 · Cited by 70
Broadbent, L., Groves, H. E., Shields, M. D., & Power, U. F. (2015) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12313 · Cited by 69
Antiviral drug discovery: Ten more compounds, and ten more stories (part B)
Clercq, E. D. (2009) · Medicinal Research Reviews · doi:10.1002/med.20149 · Cited by 69
Grillone, L. R., & Lanz, R. (2001) · Drugs of today · doi:10.1358/dot.2001.37.4.620590 · Cited by 69
Highlights in Antiviral Drug Research: Antivirals at the Horizon
Clercq, E. D. (2012) · Medicinal Research Reviews · doi:10.1002/med.21256 · Cited by 68
Amantadine and rimantadine for influenza A in children and the elderly
Galvão, M. G. A., Santos, M. A. R. C., & da Cunha, A. J. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002745.pub4 · Cited by 67
Ntemgwa, M. L., BRENNER, B. G., Oliveira, M., Moisi, D. D., & Wainberg, M. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00870-06 · Cited by 66
Wilhelmus, K. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002898.pub4 · Cited by 66
AVI-7288 for Marburg Virus in Nonhuman Primates and Humans
Heald, A. E., Charleston, J. S., Iversen, P. L., Warren, T. K., Saoud, J. B., Al-Ibrahim, M. S., Wells, J., Warfield, K. L., Swenson, D. L., Welch, L. S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410345 · Cited by 63
Functional conservation of HIV-1 Gag: implications for rational drug design
Li, G., Verheyen, J., Rhee, S., Voet, A. R. D., Vandamme, A., & Theys, K. (2013) · Retrovirology · doi:10.1186/1742-4690-10-126 · Cited by 63
Self-citationMarcellin, P., Wursthorn, K., Wedemeyer, H. H., Chuang, W., Lau, G. K. K., Ávila, C., Peng, C., Gane, E. J., Lim, S. G., Fainboim, H. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.021 · Cited by 62
Management of external genital warts.
Karnes, J., & Usatine, R. P. (2014) · PubMed · Cited by 61
Managing varicella zoster infection in pregnancy.
Gardella, C. M., & Brown, Z. A. (2007) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.74.4.290 · Cited by 60
Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus
Dayan, G. H., Pugachev, K., Bevilacqua, J., Lang, J., & Monath, T. P. C. (2013) · Viruses · doi:10.3390/v5123048 · Cited by 56
Nettles, J. H., Stanton, R. A., Broyde, J., Amblard, F., Zhang, H., Zhou, L., Shi, J., McBrayer, T. R., Whitaker, T., Coats, S. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501291c · Cited by 54
The Acyclic Nucleoside Phosphonates (ANPs): Antonín Holý's Legacy
Clercq, E. D. (2013) · Medicinal Research Reviews · doi:10.1002/med.21283 · Cited by 52
Antiviral, immunosuppressive and antitumour effects of Ribavirin
Potter, C. W., Phair, J., Vodinelich, L., FENTON, R., & Jennings, R. (1976) · Nature · doi:10.1038/259496a0 · Cited by 52
Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis
Prescott, W. A., Doloresco, F., Brown, J. E., & Paladino, J. A. (2010) · PharmacoEconomics · doi:10.2165/11531860-000000000-00000 · Cited by 51
West Nile Virus Drug Discovery
Lim, S. P., & Shi, P. (2013) · Viruses · doi:10.3390/v5122977 · Cited by 51
Baker, D. A., Ferris, D. G., Martens, M. G., et al. (2011) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2011/806105 · Cited by 50
Complications of HIV infection: a systems-based approach.
Chu, C., & Selwyn, P. A. (2011) · PubMed · Cited by 49
Palivizumab epitope–displaying virus-like particles protect rodents from RSV challenge
Schickli, J. H., Whitacre, D. C., Tang, R. S., Kaur, J., Lawlor, H. A., Peters, C. J., Jones, J. E., Peterson, D. L., McCarthy, M. P., Nest, G. V., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78450 · Cited by 48
Niet, A. D., Stelma, F., Jansen, L., Sinnige, M. J., Remmerswaal, E. B. M., Takkenberg, R. B., Kootstra, N. A., Reesink, H. W., van Lier, R. A. W., & van Leeuwen, E. M. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.013 · Cited by 47
Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease
Wang, D., & Fu, T. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.02.004 · Cited by 47
Antiviral effect of cidofovir on parvovirus B19 replication
Bonvicini, F., Bua, G., Manaresi, E., et al. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.11.004 · Cited by 46
Shedding new light on viruses: super-resolution microscopy for studying human immunodeficiency virus
Müller, B., & Heilemann, M. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.06.010 · Cited by 44
Backs against the Wall: Novel and Existing Strategies Used during the 2014-2015 Ebola Virus Outbreak
Wong, G., & Kobinger, G. P. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-15 · Cited by 43
Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era
Clercq, E. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.03.024 · Cited by 42
Elvitegravir: A Review of Its Use in Adults with HIV-1 Infection
Deeks, E. D. (2014) · Drugs · doi:10.1007/s40265-014-0206-8 · Cited by 41
Hepatitis B: 50 years after the discovery of Australia antigen
Lok, A. S.-F. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12444 · Cited by 41
Norovirus Vaccines and Potential Antinorovirus Drugs: Recent Advances and Future Perspectives
Kocher, J., & Yuan, L. (2015) · Future Virology · doi:10.2217/fvl.15.57 · Cited by 38
Boons, E., Li, G., Vanstreels, E., Vercruysse, T., Pannecouque, C. C., Vandamme, A., & Daelemans, D. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.10.007 · Cited by 37
Self-citationNew approach to managing genital warts.
Lopaschuk, C. C. (2013) · Europe PMC (PubMed Central) · Cited by 37
Pentikis, H. S., Matson, M., Atiee, G. J., Boehlecke, B. A., Hutchins, J. T., Patti, J. M., Henson, G. W., & Morris, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01446-10 · Cited by 37
Amantadine's role in the treatment of levodopa-induced dyskinesia
Rodnitzky, R. L., & Narayanan, N. S. (2013) · Neurology · doi:10.1212/wnl.0000000000000068 · Cited by 32
Nitazoxanide for chronic hepatitis C
Nikolova, K. A., Gluud, C. N., Grevstad, B., & Jakobsen, J. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009182.pub2 · Cited by 32
The race for a Zika vaccine is on
Cohen, J. (2016) · Science · doi:10.1126/science.351.6273.543 · Cited by 30
Determinants of hepatitis B and delta virus host tropism
Winer, B. Y., & Ploß, A. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.06.004 · Cited by 29
Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Famiglini, V., & Silvestri, R. (2016) · Molecules · doi:10.3390/molecules21020221 · Cited by 29
Tenofovir: Quo Vadis Anno 2012 (Where Is It Going in the Year 2012)?
Clercq, E. D. (2012) · Medicinal Research Reviews · doi:10.1002/med.21267 · Cited by 27
Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza
Yoo, J., Choi, S., Huh, J. W., Lim, C., Koh, Y., & Hong, S. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24232 · Cited by 26
The race for interferon‐free HCV therapies: a snapshot by the spring of 2012
Clercq, E. D. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.1727 · Cited by 20
Liang, J., Jiang, M. J., Deng, X., & Zhou, X. X. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.7862 · Cited by 19
FV100 as a new approach for the possible treatment of varicella-zoster virus infection
McGuigan, C., & Balzarini, J. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp294 · Cited by 19
Manzardo, C., & Gatell, J. M. (2014) · PubMed · Cited by 17
Hirsch, M. (2007) · New England Journal of Medicine · doi:10.1056/nejme078045 · Cited by 17
Systems analysis of West Nile virus infection
Suthar, M. S., & Pulendran, B. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.04.010 · Cited by 14
Li, G., Verheyen, J., Theys, K., Piampongsant, S., Laethem, K. V., & Vandamme, A. (2014) · Retrovirology · doi:10.1186/preaccept-1386531399130251 · Cited by 14
Self-citationFord, N. P., Hill, A. M., Vitória, M., & Mills, E. J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu767 · Cited by 13
Applying lessons learned from cytomegalovirus infection in transplant patients to vaccine design
Blanco-Lobo, P., Bulnes‐Ramos, Á., McConnell, M. J., Navarro, D., & Pérez‐Romero, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.03.005 · Cited by 12
N-docosanol (Abreva) for herpes labialis: Problems and questions
Spruance, S. L. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122743 · Cited by 11
Cognitively Impaired Elderly and Their Adult Children
Loue, S. (2004) · Care management journals · doi:10.1891/152109804780944486 · Cited by 10
Leporrier, J., Etienne, M., Chapuzet, C., Peytavin, G., Bord, S., Borsa-Lebas, F., Caron, F., Plantier, J., & Mourez, T. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.05.004 · Cited by 4
Cited by
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Li, G., & De Clercq, E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,729
Self-citationAgostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,416
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 831
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 828
Therapeutic strategies for COVID-19: progress and lessons learned
Li, G., Hilgenfeld, R., Whitley, R., & De Clercq, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00672-y · Cited by 676
Self-citation
Metadata
- Authors
- De Clercq, E., & Li, G.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2016-07
- Volume
- 29
- Issue
- 3
- Pages
- 695-747
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2410066853
- Cited by
- 1,430
- References
- 391
- FWCI
- 75.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.